Factors Associated with Post-Seasonal Serological Titer and Risk Factors for Infection with the Pandemic A/H1N1 Virus in the French General Population

The CoPanFlu-France cohort of households was set up in 2009 to study the risk factors for infection by the pandemic influenza virus (H1N1pdm) in the French general population. The authors developed an integrative data-driven approach to identify individual, collective and environmental factors associated with the post-seasonal serological H1N1pdm geometric mean titer, and derived a nested case-control analysis to identify risk factors for infection during the first season. This analysis included 1377 subjects (601 households). The GMT for the general population was 47.1 (95% confidence interval (CI): 45.1, 49.2). According to a multivariable analysis, pandemic vaccination, seasonal vaccination in 2009, recent history of influenza-like illness, asthma, chronic obstructive pulmonary disease, social contacts at school and use of public transports by the local population were associated with a higher GMT, whereas history of smoking was associated with a lower GMT. Additionally, young age at inclusion and risk perception of exposure to the virus at work were identified as possible risk factors, whereas presence of an air humidifier in the living room was a possible protective factor. These findings will be interpreted in light of the longitudinal analyses of this ongoing cohort.

[1]  Jeffrey Shaman,et al.  Absolute humidity modulates influenza survival, transmission, and seasonality , 2009, Proceedings of the National Academy of Sciences.

[2]  Alberto Arnedo-Pena,et al.  Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study. , 2010, Vaccine.

[3]  Weizhong Yang,et al.  The Seroprevalence of Pandemic Influenza H1N1 (2009) Virus in China , 2011, PloS one.

[4]  A. Berger,et al.  Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? , 2010, Medical Microbiology and Immunology.

[5]  Benjamin J Cowling,et al.  Household Transmission of 2009 Pandemic Influenza A (H1N1): A Systematic Review and Meta-analysis , 2012, Epidemiology.

[6]  A. Flahault,et al.  Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort , 2012, BMC Public Health.

[7]  R. Charrel,et al.  Novel Virus Influenza A (H1N1sw) in South-Eastern France, April-August 2009 , 2010, PloS one.

[8]  Mark S. Handcock,et al.  Estimating Within-School Contact Networks to Understand Influenza Transmission , 2011, The annals of applied statistics.

[9]  Libo Dong,et al.  Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. , 2009, The New England journal of medicine.

[10]  L. Rosella,et al.  Seroprevalence of Pandemic Influenza H1N1 in Ontario from January 2009–May 2010 , 2011, PloS one.

[11]  N. Andrews,et al.  Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study , 2010, The Lancet.

[12]  Thomas Lumley,et al.  Complex Surveys: A Guide to Analysis Using R , 2010 .

[13]  David L MacIntosh,et al.  Modeling the airborne survival of influenza virus in a residential setting: the impacts of home humidification , 2010, Environmental health : a global access science source.

[14]  A. Valleron,et al.  Causes of early-onset type 1 diabetes: toward data-driven environmental approaches , 2008, The Journal of experimental medicine.

[15]  Benjamin J Cowling,et al.  The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  F. Carrat,et al.  Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  F. Polack,et al.  Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes , 2010, Nature Medicine.

[18]  M. Hernandez,et al.  Airway protease/antiprotease imbalance in atopic asthmatics contributes to increased Influenza A virus cleavage and replication , 2012, Respiratory Research.

[19]  M. Stämpfli,et al.  Cigarette smoke attenuation of poly I:C-induced innate antiviral responses in human PBMC is mainly due to inhibition of IFN-beta production. , 2009, Molecular immunology.

[20]  Bonita E. Lee,et al.  Transmission of pandemic influenza A (H1N1) 2009 within households: Edmonton, Canada. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[21]  Z. Vajo,et al.  Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009–10 influenza season: a multicentre, randomised controlled trial , 2010, The Lancet.

[22]  David E. Booth,et al.  Analysis of Incomplete Multivariate Data , 2000, Technometrics.

[23]  H. Kelly,et al.  Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009. , 2011, Vaccine.

[24]  P. Holt,et al.  The effect of cigarette smoking on susceptibility to epidemic influenza and on serological responses to live attenuated and killed subunit influenza vaccines , 1976, Journal of Hygiene.

[25]  F. Carrat,et al.  Planning for the next influenza H1N1 season: a modelling study , 2010, BMC infectious diseases.

[26]  Q. S. Huang,et al.  Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic , 2010, PloS one.

[27]  F. Dawood,et al.  Household Transmission of Pandemic (H1N1) 2009, San Antonio, Texas, USA, April–May 2009 , 2010, Emerging infectious diseases.

[28]  Y. Juhn Influence of Asthma Epidemiology on the Risk for Other Diseases , 2012, Allergy, asthma & immunology research.

[29]  Wai-ming Lee,et al.  Increased H1N1 infection rate in children with asthma. , 2012, American journal of respiratory and critical care medicine.

[30]  H. Seale,et al.  Serological survey of 2009 H1N1 influenza in residents of Beijing, China , 2010, Epidemiology and Infection.

[31]  J. Kark,et al.  Cigarette smoking as a risk factor for epidemic a(h1n1) influenza in young men. , 1982, The New England journal of medicine.

[32]  Wei Zhang,et al.  Cigarette smoke extract suppresses the RIG-I-initiated innate immune response to influenza virus in the human lung. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[33]  M. Cretikos,et al.  Influenza A (H1N1) 2009 Antibodies in Residents of New South Wales, Australia, after the First Pandemic Wave in the 2009 Southern Hemisphere Winter , 2010, PloS one.

[34]  Y. Hsieh,et al.  Factors associated with infection by 2009 pandemic H1N1 influenza virus during different phases of the epidemic. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[35]  M. Stämpfli,et al.  Impairment of human NK cell cytotoxic activity and cytokine release by cigarette smoke , 2008, Journal of leukocyte biology.

[36]  Atul J. Butte,et al.  An Environment-Wide Association Study (EWAS) on Type 2 Diabetes Mellitus , 2010, PloS one.

[37]  David N. Reshef,et al.  Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009 , 2010, BMC infectious diseases.

[38]  W. Carman,et al.  Rapid communications Influenza A ( H 1 N 1 ) 2009 antibody seroprevalence in Scotland following the 2010 / 11 influenza season , 2011 .

[39]  J. Nauta,et al.  Eliminating bias in the estimation of the geometric mean of HI titres. , 2006, Biologicals : journal of the International Association of Biological Standardization.

[40]  P. Diggle,et al.  Modelling multivariate binary data with alternating logistic regressions , 1993 .

[41]  N. Ferguson,et al.  Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza , 2011, Proceedings of the National Academy of Sciences.

[42]  D. Siev Reply to "Nauta JJP, Eliminating bias in the estimation of the geometric mean of HI titers" [Biologicals 2006;34(3):183-6]. , 2007, Biologicals : journal of the International Association of Biological Standardization.

[43]  Laura C. Rosella,et al.  Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from Canada , 2010, PLoS medicine.

[44]  Kui-biao Li,et al.  Antibody Dynamics of 2009 Influenza A (H1N1) Virus in Infected Patients and Vaccinated People in China , 2011, PloS one.

[45]  J. Wood,et al.  Comparison of influenza serological techniques by international collaborative study. , 1994, Vaccine.

[46]  N. Benowitz,et al.  Cigarette smoking and infection. , 2004, Archives of internal medicine.

[47]  Anthony W. Mounts,et al.  Estimating age‐specific cumulative incidence for the 2009 influenza pandemic: a meta‐analysis of A(H1N1)pdm09 serological studies from 19 countries , 2013, Influenza and other respiratory viruses.

[48]  Xinzhang,et al.  Serologic survey of pandemic influenza A (H1N1 2009) in Beijing, China. , 2011, Preventive medicine.

[49]  Eduardo Lazcano-Ponce,et al.  Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City , 2009, BMJ : British Medical Journal.

[50]  Michel Roger,et al.  Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory‐confirmed secondary attack rates and evidence of asymptomatic infections. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  Brendan Giles,et al.  Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza , 2010, PLoS currents.

[52]  Shweta Bansal,et al.  The Shifting Demographic Landscape of Pandemic Influenza , 2010, PloS one.

[53]  A. Cook,et al.  2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. , 2010, JAMA.

[54]  S. Iamsirithaworn,et al.  Serological Response to the 2009 Pandemic Influenza A (H1N1) Virus for Disease Diagnosis and Estimating the Infection Rate in Thai Population , 2011, PloS one.

[55]  John D. Storey,et al.  Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach , 2004 .

[56]  Santosh S. Koratkar,et al.  Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India , 2010, BMC infectious diseases.

[57]  Richard K. Zimmerman,et al.  Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza in Pittsburgh, PA, USA , 2010, PloS one.

[58]  P. Simmonds,et al.  Sero-Prevalence and Incidence of A/H1N1 2009 Influenza Infection in Scotland in Winter 2009–2010 , 2011, PloS one.

[59]  R. Pebody,et al.  No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England. , 2011, Vaccine.

[60]  Kee Seng Chia,et al.  Risk Factors for Pandemic (H1N1) 2009 Seroconversion among Adults, Singapore, 2009 , 2011, Emerging infectious diseases.

[61]  B. Cowling,et al.  Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. , 2010, Clinical Infectious Diseases.

[62]  A. Flahault,et al.  Pandemic Influenza Due to pH1N1/2009 Virus: Estimation of Infection Burden in Reunion Island through a Prospective Serosurvey, Austral Winter 2009 , 2011, PloS one.

[63]  D. Skowronski,et al.  Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic , 2010, Canadian Medical Association Journal.

[64]  P. Wark,et al.  Innate immunity to influenza in chronic airways diseases , 2012, Respirology.

[65]  D B Rubin,et al.  Multiple imputation in health-care databases: an overview and some applications. , 1991, Statistics in medicine.

[66]  I. Jaspers,et al.  Epithelial cells from smokers modify dendritic cell responses in the context of influenza infection. , 2011, American journal of respiratory cell and molecular biology.

[67]  A. Flahault,et al.  Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[68]  W. Carman,et al.  Influenza A(H1N1)2009 antibody seroprevalence in Scotland following the 2010/11 influenza season. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[69]  Jin-Won Chung,et al.  Risk factors for laboratory-confirmed household transmission of pandemic H1N1 2009 infection. , 2010, American journal of infection control.